These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17149857)

  • 21. Kinase inhibitors: not just for kinases anymore.
    McGovern SL; Shoichet BK
    J Med Chem; 2003 Apr; 46(8):1478-83. PubMed ID: 12672248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling and synthesis of novel tight-binding inhibitors of cytochrome P450 2C9.
    Peng CC; Rushmore T; Crouch GJ; Jones JP
    Bioorg Med Chem; 2008 Apr; 16(7):4064-74. PubMed ID: 18255300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the absolute configuration in 1,4-dihydrothiazepine covalent complexes derived from inhibition of class A and C beta-lactamases with 6-methylidene penems.
    Mansour TS; Agarwal A; Venkatesan A; Abe T; Mihira A; Takasaki T; Sato K; Ushirogochi H; Yamamura I; Isoda T; Li Z; Yang Y; Kumagai T
    ChemMedChem; 2007 Dec; 2(12):1713-6. PubMed ID: 17868160
    [No Abstract]   [Full Text] [Related]  

  • 24. Discovery of a new class of protein farnesyltransferase inhibitors in the arylthiophene series.
    Lethu S; Ginisty M; Bosc D; Dubois J
    J Med Chem; 2009 Oct; 52(20):6205-8. PubMed ID: 19772293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Why clinically used tazobactam and sulbactam are poor inhibitors of OXA-10 beta-lactamase: Raman crystallographic evidence.
    Totir MA; Cha J; Ishiwata A; Wang B; Sheri A; Anderson VE; Buynak J; Mobashery S; Carey PR
    Biochemistry; 2008 Apr; 47(13):4094-101. PubMed ID: 18324783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.
    Mayer SC; Kreft AF; Harrison B; Abou-Gharbia M; Antane M; Aschmies S; Atchison K; Chlenov M; Cole DC; Comery T; Diamantidis G; Ellingboe J; Fan K; Galante R; Gonzales C; Ho DM; Hoke ME; Hu Y; Huryn D; Jain U; Jin M; Kremer K; Kubrak D; Lin M; Lu P; Magolda R; Martone R; Moore W; Oganesian A; Pangalos MN; Porte A; Reinhart P; Resnick L; Riddell DR; Sonnenberg-Reines J; Stock JR; Sun SC; Wagner E; Wang T; Woller K; Xu Z; Zaleska MM; Zeldis J; Zhang M; Zhou H; Jacobsen JS
    J Med Chem; 2008 Dec; 51(23):7348-51. PubMed ID: 19012391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual binding modes of Congo red to amyloid protofibril surface observed in molecular dynamics simulations.
    Wu C; Wang Z; Lei H; Zhang W; Duan Y
    J Am Chem Soc; 2007 Feb; 129(5):1225-32. PubMed ID: 17263405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic combinatorial mass spectrometry leads to metallo-beta-lactamase inhibitors.
    Liénard BM; Hüting R; Lassaux P; Galleni M; Frère JM; Schofield CJ
    J Med Chem; 2008 Feb; 51(3):684-8. PubMed ID: 18205296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of inhibition of rice bran lipase by polyphenols: a case study with chlorogenic acid and caffeic acid.
    Raghavendra MP; Kumar PR; Prakash V
    J Food Sci; 2007 Oct; 72(8):E412-9. PubMed ID: 17995599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.
    Thomson JM; Distler AM; Bonomo RA
    Biochemistry; 2007 Oct; 46(40):11361-8. PubMed ID: 17848099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Theoretical study of the reaction from 6-methylidene penem to seven-membered ring intermediates.
    Li R; Feng D; He M
    J Phys Chem A; 2007 May; 111(21):4720-5. PubMed ID: 17477514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase.
    Minkkilä A; Saario SM; Käsnänen H; Leppänen J; Poso A; Nevalainen T
    J Med Chem; 2008 Nov; 51(22):7057-60. PubMed ID: 18983140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of a novel, orally active GSK-3 inhibitor 6-Methyl-N-[3-[[3-(1-methylethoxy)propyl]carbamoyl]-1H-pyrazol-4-yl]pyridine-3-carboxamide in tau transgenic mice.
    Uno Y; Iwashita H; Tsukamoto T; Uchiyama N; Kawamoto T; Kori M; Nakanishi A
    Brain Res; 2009 Nov; 1296():148-63. PubMed ID: 19698704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-throughput screening of enzyme inhibition using an inhibitor gradient generated in a microchannel.
    Garcia E; Hasenbank MS; Finlayson B; Yager P
    Lab Chip; 2007 Feb; 7(2):249-55. PubMed ID: 17268628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Classification of cytochrome P450 inhibitors with respect to binding free energy and pIC50 using common molecular descriptors.
    Dagliyan O; Kavakli IH; Turkay M
    J Chem Inf Model; 2009 Oct; 49(10):2403-11. PubMed ID: 19777996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights into positive and negative requirements for protein-protein interactions by crystallographic analysis of the beta-lactamase inhibitory proteins BLIP, BLIP-I, and BLP.
    Gretes M; Lim DC; de Castro L; Jensen SE; Kang SG; Lee KJ; Strynadka NC
    J Mol Biol; 2009 Jun; 389(2):289-305. PubMed ID: 19332077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitors of the FEZ-1 metallo-beta-lactamase.
    Liénard BM; Horsfall LE; Galleni M; Frère JM; Schofield CJ
    Bioorg Med Chem Lett; 2007 Feb; 17(4):964-8. PubMed ID: 17157014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Internal Structure and Preferential Protein Binding of Colloidal Aggregates.
    Duan D; Torosyan H; Elnatan D; McLaughlin CK; Logie J; Shoichet MS; Agard DA; Shoichet BK
    ACS Chem Biol; 2017 Jan; 12(1):282-290. PubMed ID: 27983786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and optimization of a binding assay for histone deacetylase 4 using surface plasmon resonance.
    Mattu M; Di Giovine P; Steinkuhler C; De Francesco R; Altamura S; Cecchetti O; Carfì A; Barbato G
    Anal Biochem; 2008 Jun; 377(2):267-9. PubMed ID: 18381195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.